China's medical manufacturing industry managed to maintain its momentum amid the COVID-19 pandemic, while boosting nation's efforts of bettering its manufacturing sector and its role in the global medical supply chain, industry experts said.
The Ministry of Industry and Information Technology approved in early May the establishment of a national high-performance medical apparatus and instruments innovation center in Shenzhen, in South China's Guangdong province, marking the country's first State-level innovation center in the medical device sector.
Aiming to create a global open platform for innovation, entrepreneurship, and industrial integration, the establishment of the Shenzhen center is part of the country's strategy to drive the upgrade of its manufacturing industry.
The central authorities issued a guideline in August 2016 to build such national manufacturing innovation centers.
Currently, there are a total of 16 national manufacturing innovation centers in China. The newly established one in Shenzhen was among those centers.
"The innovation center will adopt a dynamic mechanism in market-oriented operation, innovation collaboration, intellectual property operation and a talent team. It is expected to fill the gap between academia and industry through technological innovation and engineering," said Zheng Hairong, director of the innovation center and deputy head of the Shenzhen Institutes of Advanced Technology under the Chinese Academy of Sciences.
The innovation center has gathered a batch of leading medical equipment manufacturers, including Mindray, United Imaging, and LifeTech Scientific Corp. There are also research institutes in the center such as the Shenzhen Institutes of Advanced Technology under the Chinese Academy of Sciences.
Source: China Daily
